BioNTech SE Ownership | Who Owns BioNTech SE?


OverviewForecastChartTranscripts

BioNTech SE Ownership Summary


BioNTech SE is owned by 19.10% institutional investors, 57.42% insiders, and 23.48% retail investors. T. rowe price investment management is the largest institutional shareholder, holding 2.42% of BNTX shares. Franklin All Country World ex US Equity is the top mutual fund, with 8.32% of its assets in BioNTech SE shares.

BNTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioNTech SE19.10%57.42%23.48%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
T. rowe price investment management5.86M2.42%$520.49M
Fmr5.71M2.36%$507.44M
Primecap management co/ca/3.79M1.57%$337.19M
Flossbach von storch3.68M1.52%$327.11M
Dodge & cox3.68M1.52%$326.79M
Blackrock1.90M0.79%$152.32M
Blackrock funding, inc. /de1.66M0.69%$147.38M
Bnp paribas arbitrage, snc1.65M0.68%$146.81M
Temasek (private)1.51M0.62%$133.86M
Citadel advisors951.37K0.39%$84.56M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bill & melinda gates foundation148.67K19.99%$11.95M
Gsk889.82K13.20%$79.09M
Davern capital partners, lp305.06K7.44%$27.11M
Logos global management lp300.00K4.00%$34.19M
Tang capital management470.00K2.12%$41.77M
Krensavage asset management59.52K2.07%$5.29M
Crocodile capital partners gmbh29.59K2.02%$2.82M
Sectoral asset management22.16K1.69%$2.05M
Flossbach von storch3.68M1.53%$327.11M
Long focus capital management624.00K1.46%$55.46M

Top Buyers

HolderShares% AssetsChange
T. rowe price investment management5.86M0.36%1.37M
Massachusetts financial services co /ma/670.51K0.02%670.51K
Ubs asset management americas784.00K0.01%533.66K
Blackrock funding, inc. /de1.66M0.00%505.27K
First trust advisors lp839.99K0.05%451.12K

Top Sellers

HolderShares% AssetsChange
Pfizer---1.66M
Capital investors---1.13M
Jane street group336.76K0.00%-1.02M
Capital world investors---955.98K
Viking global investors lp---879.97K

New Positions

HolderShares% AssetsChangeValue
Massachusetts financial services co /ma/670.51K0.02%670.51K$59.60M
Logos global management lp300.00K4.00%300.00K$34.19M
Ark investment management127.88K0.09%127.88K$11.37M
Ghisallo capital management125.00K0.40%125.00K$12.33M
Longaeva partners119.20K0.39%119.20K$10.59M

Sold Out

HolderChange
Halbert hargrove global advisors-1.00
Clear street markets-1.00
Gps wealth strategies group-1.00
Cornerstone planning group-1.00
Harbor investment advisory-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026291-8.49%46,165,527-3.61%194.76%129-12.24%72-10.00%
Dec 31, 2025143-50.35%16,971,235-66.39%71.62%60-43.40%37-59.78%
Sep 30, 2025105-62.09%20,093,114-62.09%81.71%36-70.97%37-51.32%
Jun 30, 2025283-8.41%53,736,1354.22%224.86%12211.93%80-22.33%
Mar 31, 2025310-8.55%51,726,3571.91%214.80%108-28.95%10523.53%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Franklin All Country World ex US Equity20.00M8.32%20.00M
FvS SICAV Multiple Opportunities F2.73M1.08%-
Dodge & Cox International Stock I2.52M1.00%-
T. Rowe Price Capital Appreciation2.27M0.90%828.70K
Vanguard Capital Opportunity Inv2.19M0.87%-2.60K
Fidelity Contrafund2.04M0.81%618.93K
Harding Loevner International Eq Instl1.29M0.54%-561.45K
FvS Multiple Opportunities II I1.13M0.45%-
T. Rowe Price US Mid-Cap Growth Equity1.02M0.40%-900.00
T. Rowe Price Mid-Cap Growth1.02M0.40%-

Recent Insider Transactions


DateNameRoleActivityValue
Apr 22, 2026Poetting Sierk Chief Operating OfficerSell$5.53M

Insider Transactions Trends


DateBuySell
2029 Q2--
2027 Q2--
2026 Q2--
2026 Q1--
2025 Q2--

BNTX Ownership FAQ


Who Owns BioNTech SE?

BioNTech SE shareholders are primarily institutional investors at 19.10%, followed by 57.42% insiders and 23.48% retail investors. The average institutional ownership in BioNTech SE's industry, Biotech Stocks , is 35.75%, which BioNTech SE falls below.

Who owns the most shares of BioNTech SE?

BioNTech SE’s largest shareholders are T. rowe price investment management (5.86M shares, 2.42%), Fmr (5.71M shares, 2.36%), and Primecap management co/ca/ (3.79M shares, 1.57%). Together, they hold 6.35% of BioNTech SE’s total shares outstanding.

Does Blackrock own BioNTech SE?

Yes, BlackRock owns 0.79% of BioNTech SE, totaling 1.9M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 152.32M$. In the last quarter, BlackRock decreased its holdings by -11.414K shares, a -0.60% change.

Who is BioNTech SE’s biggest shareholder by percentage of total assets invested?

Bill & melinda gates foundation is BioNTech SE’s biggest shareholder by percentage of total assets invested, with 19.99% of its assets in 148.67K BioNTech SE shares, valued at 11.95M$.

Who is the top mutual fund holder of BioNTech SE shares?

Franklin All Country World ex US Equity is the top mutual fund holder of BioNTech SE shares, with 8.32% of its total shares outstanding invested in 20M BioNTech SE shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools